JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB176243

Anti-p53 antibody [PAb 240] - BSA and Azide free

Be the first to review this product! Submit a review

|

(3 Publications)

Mouse Monoclonal P53 antibody. Carrier free. Suitable for IP, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 3 publications.

View Alternative Names

P53, Trp53, Tp53, Cellular tumor antigen p53, Tumor suppressor p53

6 Images
Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)
  • WB

Lab

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)

Lanes 1-2 : 1% BSA blocking buffer

Lanes 3-4 : 3% Milk blocking buffer

We recommend using 3% milk as the blocking agent for Western blot.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, L-Arginine and sodium azide (ab26).

Lanes 1 - 2:

Western blot - Anti-p53 antibody [PAb 240] (<a href='/en-us/products/primary-antibodies/p53-antibody-pab-240-ab26'>ab26</a>) at 1 µg/mL

Lanes 3 - 4:

Western blot - Anti-p53 antibody [PAb 240] (<a href='/en-us/products/primary-antibodies/p53-antibody-pab-240-ab26'>ab26</a>) at 5 µg/mL

All lanes:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg

Secondary

All lanes:

Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/5000 dilution

Predicted band size: 43 kDa

true

Exposure time: 4min

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)
  • WB

Lab

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab26 overnight at 4°C. Antibody binding was detected using an anti-mouse HRP secondary antibody (ab97040), and visualised using ECL development solution ab133406.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, L-Arginine and sodium azide (ab26).

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (<a href='/en-us/products/primary-antibodies/p53-antibody-pab-240-ab26'>ab26</a>) at 1 µg/mL

All lanes:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/50000 dilution

Predicted band size: 43 kDa

Observed band size: 53 kDa

true

Exposure time: 8min

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)
  • WB

Project10191****

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)

This data was developed using the same antibody clone in a different buffer formulation containing PBS, L-Arginine and sodium azide (ab26).

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (<a href='/en-us/products/primary-antibodies/p53-antibody-pab-240-ab26'>ab26</a>) at 5 µg/mL

Lane 1:

HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 20 µg

Lane 2:

Hela Whole Cell Lysate - Bleomycin Treated (40U/ml) at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/5000 dilution

Predicted band size: 43 kDa

true

Exposure time: 4min

Immunoprecipitation - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)
  • IP

Supplier Data

Immunoprecipitation - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)

p53 was immunoprecipitated from 7x106 HCT116 (human colon carcinoma cell line) cells with ab26 at 1/150 dilution. Western blot was performed from the immunoprecipitate using anti-p53 antibody. Donkey Anti-Mouse IgG H&L (Alexa Fluor® 750) preadsorbed (ab175739) was used as secondary antibody at 1/5000 dilution.

Lane 1 : HCT116 whole cell lysate 10 μg (Input).

Lane 2 : ab207799 IP in etoposide treated HCT116 whole cell lysate.

Lane 3 : ab207799 IP in etoposide treated HCT116 p53-/- whole cell lysate (negative control).

This data was developed using the same antibody clone in a different buffer formulation containing PBS, L-Arginine and sodium azide (ab26).

All lanes:

Immunoprecipitation - Anti-p53 antibody [PAb 240] - BSA and Azide free (ab176243)

Predicted band size: 43 kDa

false

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)
  • WB

Unknown

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)

Primary : All Lanes : Anti-p53 antibody (ab26) at 5 μg/mL. Lane 1 : MW marker. Lane 2 : NIH/3T3 cells treated with vehicle for 24 hours. Lane 3 : NIH/3T3 cells treated with 1 μM doxorubicin for 24 hours Secondary : All Lanes : HRP-conjugated VeriBlot anti-Mouse IgG (ab131368) 1 : 1000. Lysates at 20 μg/lane. Performed under denaturing conditions. Developed using ECL technique. Blocking buffer : 5% milk in PBS.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, L-Arginine and sodium azide (ab26).

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (<a href='/en-us/products/primary-antibodies/p53-antibody-pab-240-ab26'>ab26</a>)

Predicted band size: 43 kDa

false

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)
  • WB

Supplier Data

Western blot - Anti-p53 antibody [PAb 240] - BSA and Azide free (AB176243)

Lanes 1-6 : Merged (red and green) signal.

ab26 was shown to specifically react with p53 in wild type HCT116 cells treated with irinotecan. No band was observed in p53 knockout HCT116 cells. Wild-type and p53 knockout samples, positive and negative controls were subjected to SDS-PAGE. ab26 and ab181602 (loading control to GAPDH) were diluted 5 μg/mL and 1/10,000 respectively and incubated overnight at 4°C. Blots were developed with goat anti-rabbit IgG (H + L) and goat anti-mouse IgG (H + L) secondary antibodies at 1/10,000 dilution for 1 h at room temperature before imaging.

Wild-type and p53 knockout HCT116 cell lysates were kindly provided by a collaborator.

This data was developed using the same antibody clone in a different buffer formulation containing PBS, L-Arginine and sodium azide (ab26).

All lanes:

Western blot - Anti-p53 antibody [PAb 240] (<a href='/en-us/products/primary-antibodies/p53-antibody-pab-240-ab26'>ab26</a>) at 5 µg/mL

Lane 1:

Wild-type HCT116 cell lysate at 30 µg

Lane 2:

Wild-type HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg

Lane 3:

p53 knockout HCT116 cell lysate at 30 µg

Lane 4:

p53 knockout HCT116 + irinotecan (10 µM, 24 hours) cell lysate at 30 µg

Lane 5:

A431 cell lysate (positive control) at 20 µg

Lane 6:

Saos-2 cell lysate (negative control) at 20 µg

Predicted band size: 43 kDa

Observed band size: 53 kDa

false

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

PAb 240

Isotype

IgG1

Light chain type

kappa

Carrier free

Yes

Reacts with

Mouse, Human

Applications

WB, ICC/IF, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Epitope

The epitope has been mapped between amino acids 213 and 217 on human p53.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p>Please note that expression of target protein may be very low without stimulation/treatment (e.g. DNA damaging agent). We recommend using 3% milk as the blocking agent for Western blot.</p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "5 µg/mL", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p>Please note that expression of target protein may be very low without stimulation/treatment (e.g. DNA damaging agent). We recommend using 3% milk as the blocking agent for Western blot.</p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Cow": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Dog": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Syrian hamster": { "IP-species-checked": "predicted", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

This product is the BSA- and Azide-Free version of Mouse Monoclonal [PAb 240] to p53 (ab26).

Properties and storage information

Form
Liquid
Purity
IgG fraction
Storage buffer
Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein p53 also known as TP53 or tumor protein p53 has a molecular weight of approximately 53 kDa. It acts as a transcription factor and plays a major role in cell cycle regulation apoptosis and maintaining genomic stability. This protein mainly expresses in the nucleus of cells and acts as a critical regulator of cellular responses to stress signals including DNA damage. Scientists commonly use p53 antibodies in various assays like western blot and p53 immunofluorescence to detect and study its expression and functional status in cells.
Biological function summary

P53 functions to control cell division and apoptosis serving as a guardian of the genome by preventing mutation accumulation. It does not form part of a larger complex under normal conditions but interacts with various other molecules to execute its functions. p53 can activate or suppress the transcription of numerous genes involved in cell cycle arrest DNA repair and programmed cell death allowing it to halt the progression of damaged cells and trigger repair mechanisms or eliminate those that cannot be repaired.

Pathways

P53 acts within several key biological pathways such as the p53 signaling pathway and the intrinsic apoptotic pathway. Its activity involves interaction with proteins like MDM2 which regulates p53 through ubiquitin-mediated degradation and ATM kinase which phosphorylates p53 in response to DNA damage. These interactions ensure appropriate cellular responses during stress and are vital for maintaining homeostasis.

P53 mutation or inactivation is often associated with the development of cancer given its role in controlling cell division and preventing tumor formation. Specifically its dysfunction has been linked to cancers such as breast cancer and lung cancer. Additionally p53 can interact with other mutant proteins like Ras compounding mutations that contribute to tumor progression and aggressive cancer phenotypes. Understanding these interactions and the status of p53 can be important in developing targeted cancer therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Multifunctional transcription factor that induces cell cycle arrest, DNA repair or apoptosis upon binding to its target DNA sequence (PubMed : 19556538, PubMed : 20673990, PubMed : 22726440). Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Negatively regulates cell division by controlling expression of a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (By similarity). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (By similarity). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression (By similarity). Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA-Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis, but seems to have to effect on cell-cycle regulation. Regulates the circadian clock by repressing CLOCK-BMAL1-mediated transcriptional activation of PER2 (PubMed : 24051492).
See full target information Tp53

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

Veterinary medicine and science 9:1426-1437 PubMed36920334

2023

Evaluation of the in vitro and in vivo effect of liposomal doxorubicin along with oncolytic Newcastle disease virus on 4T1 cell line: Animal preclinical research.

Applications

Unspecified application

Species

Unspecified reactive species

Pooya Faranoush,Alireza Jahandideh,Reza Nekouian,Pejman Mortazavi

Cancer medicine 10:7475-7491 PubMed34626092

2021

Positive electrostatic therapy of metastatic tumors: selective induction of apoptosis in cancer cells by pure charges.

Applications

Unspecified application

Species

Unspecified reactive species

Ashkan Zandi,Saeid Rafizadeh-Tafti,Fatemeh Shojaeian,Mohammad Ali Khayamian,Fereshteh Abbasvandi,Mohammad Faranoush,Robab Anbiaee,Sahar Najafikhoshnoo,Parisa Hoseinpour,Sepanta Assadi,Pouyan Katebi,Zahra Davari Sh,Shahriar Shalileh,Mohammad Salemizadeh Parizi,Shohreh Vanaei,Mohammadreza Ghaderinia,Hamed Abadijoo,Payam Taheri,Mohammad Reza Esmailinejad,Hassan Sanati,Mohammad Reza Rostami,Reza Sadeghian,Yasin Kordehlachin,S M Sadegh Mousavi-Kiasary,Amir Mamdouh,Seyyed Hossein Miraghaie,Hossein Baharvand,Mohammad Abdolahad

EMBO molecular medicine 8:1019-38 PubMed27390132

2016

SLC25A46 is required for mitochondrial lipid homeostasis and cristae maintenance and is responsible for Leigh syndrome.

Applications

Unspecified application

Species

Unspecified reactive species

Alexandre Janer,Julien Prudent,Vincent Paupe,Somayyeh Fahiminiya,Jacek Majewski,Nicolas Sgarioto,Christine Des Rosiers,Anik Forest,Zhen-Yuan Lin,Anne-Claude Gingras,Grant Mitchell,Heidi M McBride,Eric A Shoubridge
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com